American society of clinical oncology policy for relationships with companies: Background and rationale

Journal of Clinical Oncology

Volumn 31, Issue 16, 2013, Pages 2037-2042

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; EVALUATION STUDY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INDEPENDENCE; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; MEDICAL SOCIETY; PEER REVIEW; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; STANDARD; DRUG INDUSTRY; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; ONCOLOGY; PRACTICE GUIDELINE; RESEARCH; RESEARCH ETHICS; UNITED STATES; WRITING;

AUTHORSHIP; CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; ETHICS, RESEARCH; GUIDELINES AS TOPIC; HEALTH CARE SECTOR; HUMANS; MEDICAL ONCOLOGY; RESEARCH; RESEARCH SUPPORT AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84880650200     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.4997     Document Type: Article

References (27)

1. Accreditation Council for Continuing Medical Education: Standards for commercial support: Standards to ensure independence in CME activities. http://www.accme.org/requirements/accreditation-requirements- cme-providers/standards-for-commercial-support
2. American Society of Clinical Oncology: American Society of Clinical Oncology: Policy for relationships with companies. J Clin Oncol 31:2043-2046, 2013
3. American Society of Clinical Oncology: American Society of Clinical Oncology: Revised conflict of interest policy. J Clin Oncol 24:519-521, 2006
4. American Society of Clinical Oncology: American Society of Clinical Oncology: Revised conflict of interest policy. J Clin Oncol 21:2394-2396, 2003
5. Lockhart AC, Brose MS, Kim ES, et al: Physician and stakeholder perceptions of conflict of interest policies in oncology. J Clin Oncol [epub ahead of print on March 25, 2013]
6. American Society of Clinical Oncology: The Quality Oncology Practice Initiative. http://qopi.asco.org/
7. American Society of Clinical Oncology: Clinical Practice Guidelines. http://www.asco.org/institute-quality/guidelines
8. American Society of Clinical Oncology: Cancer Learning Intelligence Network for Quality (CancerLinQ). http://www.asco.org/institute-quality/ cancerlinq
9. Harris G: Senator Grassley seeks financial details from medical groups. New York Times, December 7, 2009
10. Ramshaw E, Murphy R: Payments to doctors by pharmaceutical companies raise issues of conflicts. New York Times, November 24, 2011:A27A
11. Rothman DJ, McDonald WJ, Berkowitz CD, et al: Professional medical associations and their relationships with industry: A proposal for controlling conflict of interest. JAMA 301:1367-1372, 2009
12. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice: Conflict of interest in medical research, education, and practice. http://www.iom.edu/Reports/2009/Conflict-of-Interest- in-Medical-Research-Education-and-Practice.aspx
13. Eli Lilly: Lilly physician payment registry: Monday, December 10, 2012 update. http://www.lillyphysician-paymentregistry.com/
14. Janssen: Physician payment report: December 19, 2012 update. http://www.hcctransparency.com/report/janssenpharmaceuticalsinc/134/hcp/yearly
15. Disclosure of Allowable Expenditures and Gifts by Manufacturers of Prescribed Products, 18 V.S.A. §4632
16. Minnesota Payments Disclosure Law, Minn Stat §151.47(f)
17. Transparency Reports and Reporting of Physician Ownership or Investment Interests, 42 USC §1320a-7h (2013)
18. Moy B, Bradbury AR, Helft PR, et al: Correlation between financial relationships with commercial interests and research prominence at an oncology meeting. J Clin Oncol doi: 10.1200/JCO.2012.46.6375
19. Drazen JM, de Leeuw PW, Laine C, et al: Toward more uniform conflict disclosures: The updated ICMJE conflict of interest reporting form. JAMA 304:212-213, 2010
20. Lichter AS, McKinney R: Toward a harmonized and centralized conflict of interest disclosure: Progress from an IOM initiative. JAMA 308:2093-2094, 2012
21. Lichter AS, McKinney R, Anderson T, et al: Harmonizing reporting on potential conflicts of interest: A common disclosure process for health care and life sciences. National Academy of Sciences, 2012
22. Kesselheim AS, Orentlicher D: Introduction: Insights from a national conference: "Conflicts of interest in the practice of medicine." J Law Med Ethics 40:436-440, 2012
23. Journal of Oncology Practice: About JOP. http://jop.ascopubs.org/site/ misc/about.xhtml
24. Okike K, Kocher MS, Wei EX, et al: Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 361:1466-1474, 2009
25. Jagsi R, Sheets N, Jankovic A, et al: Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer 115:2783-2791, 2009
26. Loewenstein G, Sah S, Cain DM: The unintended consequences of conflict of interest disclosure. JAMA 307:669-670, 2012
27. Saver RS: Is it really all about the money? Reconsidering non-financial interests in medical research. J Law Med Ethics 40:467-481, 2012